Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional phosphatidylcholine injections for reduction of thigh fat
2006-000371-15Phase 3Completed
- Sponsor
- no sponsor for this trial
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of phosphatidylcholine in localized adiposity (AL), sponsored by no sponsor for this trial. Primary endpoints: Evaluation of the lipolytic effect of phosphatidylcholine and Extent of achievable fat reduction. Started Mar 2006; status: completed.
02
Drugs
phosphatidylcholine
03
Conditions
localized adiposity (AL)
Beyond the preview
Go deeper on 2006-000371-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000371-15.